Literature DB >> 12580973

Oral anticoagulants in the elderly.

Paul Froom1, Ehud Miron, Mira Barak.   

Abstract

Over a 1-year period, 34,998 prothrombin time tests were performed on 2,379 patients aged 40-89 years with a recommended target International Normalized Ratio (INR) value of 2.5. At least one INR value of >/= 5 was found in 507/2,379 patients (21.3%). The elderly demonstrated higher maximum and lower minimum INR values, lower warfarin doses, and an increased number of tests performed. After adjustment for these factors, the risk of INR values >/= 5 increased with age by 15% every 10 years (95% CI 4-28%). We conclude that age is a risk factor for more unstable prothrombin time results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12580973     DOI: 10.1046/j.1365-2141.2003.04110.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

Review 1.  Mechanical circulatory support for elderly heart failure patients.

Authors:  Craig R Butler; Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

2.  Use of vitamin K antagonist therapy in geriatrics: a French national survey from the French Society of Geriatrics and Gerontology (SFGG).

Authors:  Matthieu Plichart; Gilles Berrut; Nathalie Maubourguet; Claude Jeandel; Jean-Paul Emeriau; Joël Ankri; Hélène Bouvier; Geneviève Ruault; Olivier Hanon
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

3.  Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population.

Authors:  Letícia C Tavares; Nubia E Duarte; Leiliane R Marcatto; Renata A G Soares; Jose E Krieger; Alexandre C Pereira; Paulo Caleb Junior Lima Santos
Journal:  Eur J Clin Pharmacol       Date:  2018-07-26       Impact factor: 2.953

4.  Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial.

Authors:  Shunichi Homma; John L P Thompson; Alexandra R Sanford; Douglas L Mann; Ralph L Sacco; Bruce Levin; Patrick M Pullicino; Ronald S Freudenberger; John R Teerlink; Susan Graham; J P Mohr; Barry M Massie; Arthur J Labovitz; Marco R Di Tullio; André P Gabriel; Gregory Y H Lip; Conrado J Estol; Dirk J Lok; Piotr Ponikowski; Stefan D Anker
Journal:  Circ Heart Fail       Date:  2013-07-23       Impact factor: 8.790

Review 5.  Optimizing the use of anticoagulants (heparins and oral anticoagulants) in the elderly.

Authors:  Virginie Siguret; Isabelle Gouin-Thibault; Pascale Gaussem; Eric Pautas
Journal:  Drugs Aging       Date:  2013-09       Impact factor: 3.923

6.  Relationship between diet and anticoagulant response to warfarin: a factor analysis.

Authors:  Silvia Maria Custódio das Dôres; Sarah L Booth; Ligia Araújo Martini; Ligia Aújo Martini; Victor Hugo de Carvalho Gouvêa; Carlos Roberto Padovani; Francisco Humberto de Abreu Maffei; Alvaro Oscar Campana; Sérgio Alberto Rupp de Paiva
Journal:  Eur J Nutr       Date:  2007-03-13       Impact factor: 5.614

Review 7.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

Review 8.  Haemorrhagic complications of vitamin k antagonists in the elderly: risk factors and management.

Authors:  Eric Pautas; Isabelle Gouin-Thibault; Matthieu Debray; Pascale Gaussem; Virginie Siguret
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

9.  Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study.

Authors:  Kim Ekblom; Johan Hultdin; Bo Carlberg; Tage Strand
Journal:  Thromb J       Date:  2005-12-08

10.  Factors influencing warfarin response in hospitalized patients.

Authors:  Mahmoud I Abdel-Aziz; Mostafa A Sayed Ali; Ayman K M Hassan; Tahani H Elfaham
Journal:  Saudi Pharm J       Date:  2015-02-27       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.